Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Open-market sale Chief Financial Officer sold 1,069 shares at $5.93 ($6,339)
  2. 4 Open-market buy Director bought 1,700 shares at $5.51 ($9,367)
  3. 4 Exercise or conversion Chief Financial Officer acquired 10,000 shares (option exercise)
  4. 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
  5. 4 Open-market buy Director bought 5,438 shares at an average $5.31 ($28,874)
  6. 4 Open-market sale President and CEO sold 25,000 shares at $20.00 ($500,000)
  7. 4 Open-market sale Chief Financial Officer sold 1,082 shares at $17.87 ($19,335)
  8. 4 Open-market sale Chief Commercial Officer sold 1,027 shares at an average $17.89 ($18,372)
  9. 4 Open-market sale General Counsel sold 1,082 shares at an average $17.88 ($19,350)
  10. 4 Open-market sale President and CEO sold 2,940 shares at $17.87 ($52,538)
  11. 4 Open-market sale President and CEO sold 50,000 shares at $20.59 ($1,029,500)
  12. 4 Grant or award Director acquired 5,600 shares (grant or award)
  13. 4 Grant or award Director acquired 5,600 shares (grant or award)
  14. 4 Grant or award Director acquired 5,600 shares (grant or award)
  15. 4 Grant or award Director acquired 5,600 shares (grant or award)
  16. 4 Open-market sale Chief Commercial Officer sold 1,011 shares at $18.05 ($18,249)
  17. 4 Open-market sale Chief Financial Officer sold 1,065 shares at $18.05 ($19,223)
  18. 4 Grant or award Director acquired 5,600 shares (grant or award)
  19. 4 Open-market sale President and CEO sold 2,523 shares at $18.05 ($45,540)
  20. 4 Open-market sale General Counsel sold 1,065 shares at $18.05 ($19,223)

Page 7 of 12 · 229 filings